Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2991841000168115 | Citanest 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2991851000168118 | Citanest (prilocaine hydrochloride 250 mg / 50 mL) injection, 5 x 50 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Citanest (prilocaine hydrochloride 250 mg / 50 mL) injection, 5 x 50 mL vials (trade product pack) | Is a | trade product pack | true | Inferred relationship | Some | ||
| Citanest (prilocaine hydrochloride 250 mg / 50 mL) injection, 5 x 50 mL vials (trade product pack) | Is a | prilocaine hydrochloride 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | true | Inferred relationship | Some | ||
| Citanest (prilocaine hydrochloride 250 mg / 50 mL) injection, 5 x 50 mL vials (trade product pack) | has TPUU | Citanest 0.5% (250 mg/50 mL) injection, 50 mL vial | true | Inferred relationship | Some | 1 | |
| Citanest (prilocaine hydrochloride 250 mg / 50 mL) injection, 5 x 50 mL vials (trade product pack) | has TP | Citanest | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Citanest 0.5% (250 mg/50 mL) injection, 5 x 50 mL vials | Is a | True | Citanest (prilocaine hydrochloride 250 mg / 50 mL) injection, 5 x 50 mL vials (trade product pack) | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR